FDA Approves First Gene Therapy for Bladder Cancer Patients with BCG-unresponsive bladder cancer  had limited treatment options other than bladder removal surgery. The approval of Adstiladrin is therefore a great advance in the current treatment landscape and provides a novel treatment option.

©2023 - Herts & Essex Urology | Company Reg No: 7205080

My Agile Privacy
This website uses technical and profiling cookies. Clicking on "Accept" authorises all profiling cookies. Clicking on "Refuse" or the X will refuse all profiling cookies. By clicking on "Customise" you can select which profiling cookies to activate.
Warning: some page functionalities could not work due to your privacy choices